Stock Report

All about this stock under one free report Last Updated: 04-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Shree Bio-Tech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 539470

₹0.49

up-down-arrow ₹0.01 (2.08%)

As on 04-Sep-2026 10:38IST

Market cap

info icon

₹19 Cr

Revenue (TTM)

info icon

₹5 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -32.58 3.32 -75.87 -53.55 -31.25
EBIT -109.13 -914.77 -74.75 -216.47 -204.26
Net Profit -279.47 -275.23 -181.34 -160.93 -181.14
EPS -278.95 -275.61 -180.83 -160.83 -181.98
Book Value -- -- 0.44 1.60 1.94
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info -0.711.34-35.19-4.59-0.99
Net Margin info 2.432.69-6.071.142.91
Return on equity info 1.591.92-0.610.440.99
Return on Capital info 2.132.61--0.611.36
Return on Assets info 1.191.41-0.610.410.81
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
0.61
1.36
4.43
5.92
Peer Median
--
16.69
14.62
11.30
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-0.61

Lower than Peers by 14.21

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
-0.61
0.44
0.99
3.32
4.28
Peer Median
13.60
20.05
11.57
8.83
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-0.61

Lower than Peers by 7.52

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
-0.61
0.41
0.81
2.36
3.00
Peer Median
6.91
11.42
4.57
5.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-35.19

Lower than Peers by 42.10

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
-35.19
-4.59
-0.99
3.44
4.75
Peer Median
6.91
9.04
8.83
8.30
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-6.07

Lower than Peers by 11.57

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
-6.07
1.14
2.91
3.24
3.47
Peer Median
5.50
11.50
4.52
3.27
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
0.00
1.21
3.06
3.27
3.48
Peer Median
--
--
--
0.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-75.87

Lower than Peers by 89.46

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
-75.87
13.22
-67.53
-14.03
322.01
Peer Median
13.59
15.57
15.22
46.63
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-74.75

Lower than Peers by 78.40

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
-74.75
-423.60
-109.37
-37.68
387.48
Peer Median
3.65
5.87
15.30
113.31
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-181.34

Lower than Peers by 188.03

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
-181.34
-55.15
-69.55
-19.29
697.39
Peer Median
6.69
3.10
13.95
108.18
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-180.83

--

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
-180.83
-55.13
-69.47
-19.40
702.53
Peer Median
--
1.38
5.26
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
0.44
1.00
3.38
4.37
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
--
--
--
--
Peer Median
0.02
0.24
0.31
0.31
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

70.02

Higher than Peers by 68.01

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
70.02
14.65
0.35
1.16
1.32
Peer Median
2.01
2.02
1.80
1.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.01

Lower than Peers by 0.15

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
1.01
2.18
0.35
1.16
1.32
Peer Median
1.17
0.95
0.93
1.95
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
--
8,550.00
--
--
Peer Median
5.39
7.46
4.54
3.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
--
16.29
30.95
60.42
Peer Median
22.01
18.52
21.56
32.87
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.08

Lower than Peers by 0.96

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
0.08
0.33
0.26
0.72
0.86
Peer Median
1.04
1.34
1.29
1.15
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
--
203.69
184.73
181.46
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
45.95
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
--
244.63
149.35
129.48
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
--
-40.94
35.38
51.98
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

-49.32

Lower than Peers by 63.52

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
-49.32
128.57
67.31
19.96
36.70
Peer Median
14.20
20.37
21.32
24.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.30

Lower than Peers by 1.40

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
0.30
0.57
0.66
0.65
3.07
Peer Median
1.70
2.46
3.72
1.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-49.42

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
-49.42
92.57
48.42
14.80
52.95
Peer Median
--
15.92
19.83
16.34
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

19

Lower than Peers by 338

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Shree Bio-Tech
19
36
42
41
185
Peer Median
357
706
421
209
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...